Quick Answer
Alpha Tau Medical Ltd. reported Cash and Equivalents of $12.20 million for fiscal year 2025.
Alpha Tau Medical Ltd. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $12.20M | -11.1% |
| 2024 | $13.72M | +8.4% |
| 2023 | $12.66M | +116.9% |
| 2022 | $5.84M | -74.9% |
| 2021 | $23.24M | +49.0% |
| 2020 | $15.60M | — |
- Alpha Tau Medical Ltd. showed a decrease of -11.1% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2020–2025 period, Alpha Tau Medical Ltd.’s cash and equivalents has declined by 21.8% (from $15.60 million to $12.20 million).
- The most recent figure is from Alpha Tau Medical Ltd.’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 9, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: